Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

Clinical trial NCT06325046 · RECRUITING

Trial details

NCT number: NCT06325046
Sponsor: Mayo Clinic
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Localized Prostate Adenocarcinoma Stage I Prostate Cancer AJCC v8 Stage II Prostate Cancer AJCC v8 Stage III Prostate Cancer AJCC v8

Start date: 2024-08-15
Primary completion: 2026-08-30
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.